Tavapadon
Pwodwi detay
Tags pwodwi
Gwosè pake | Disponibilite | Pri (USD) |
10 mg | Nan Stock | 210 |
100 mg | Nan Stock | 450 |
1g | Nan Stock | 1900 |
Non chimik:
1,5-dimethyl-6-[2-methyl-4-[3-(trifluoromethyl)pyridin-2-yl]oxyphenyl]pyrimidine-2,4-dyon
Kòd SMILES:
O=C1NC(C(C)=C(C2=CC=C(OC3=NC=CC=C3C(F)(F)F)C=C2C)N1C)=O
Kòd InChi:
InChI=1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17 )6-7-13(10)15-11(2)16(26)24-18(27)25(15)3/h4-9H,1-3H3,(H,24,26,27)
InChi kle:
AKQXQLUNFKDZBN-UHFFFAOYSA-N
Mot:
1643489-24-0;CAS:1643489-24-0;CAS:1643489-24-0;Tavapadon; PF-6649751; PF 6649751; PF6649751; CVL-751; CVL 751; CVL751
Solibilite:Soluble nan DMSO
Depo:Sèk, nwa ak nan 0 - 4 C pou kout tèm (jou a semèn) oswa -20 C pou tèm long (mwa a ane).
Deskripsyon:
Tavapadon, ke yo rele tou PF-6649751 ak CVL-751, se yon agonist reseptè dopamine pasyèl. Li ka itil nan tretman maladi Parkinson la ak alzayme a.
Sib: Dopamine d1/d5 reseptè agonist pasyèl